Medical Affairs Research
Medical Affairs Resources, Structures & Trends
|
Non-members: Click here to review a complimentary excerpt from "Medical Affairs Resources, Structures & Trends"
Study Overview
Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important functions -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency... (ID 5049)
Companies Profiled: Amgen, Astellas, AstraZeneca Pharmaceuticals, Bayer Schering AG, more ...
Price: $4100.00 Free Excerpt Available
| |
Best Practices in Utilizing Health Outcomes Data
|
Non-members: Click here to review a complimentary excerpt from "Best Practices in Utilizing Health Outcomes Data"
Study Overview
Optimizing the utilization of Health Outcomes data has become increasingly important to the success of biotechnology and pharmaceutical companies... (ID 5043)
Companies Profiled: Abbott, Alfred Mann Foundation, ASSESSmint, Baxter, more ...
Price: $4000.00 Free Excerpt Available
| |
Corporate Medical Services: Administration Excellence
|
Non-members: Click here to sign-up for a complimentary tour of
"Corporate Medical Services: Administration Excellence"
Study Overview
In today's economy, maintaining low costs is essential to the business function... (ID 4799)
Companies Profiled: Boeing, DTE Energy, Bombardier Aerospace, Osram Sylvania, more ...
Price: $2495.00
| |
Medical Affairs Staffing & Spend: Maximizing Value, Decreasing Cost
|
Study Overview
With new pressures and regulations, pharmaceutical companies are looking for more ways then ever to decrease the cost of maintaining their medical affairs department, mostly through staffing and expenditure... (ID 4631)
Companies Profiled: Abbott, Sanofi-aventis, Amgen, AstraZeneca, more ...
Price: $1584.95
| |
Building Effective Structures for Patient Advocacy Relations
|
As patient advocacy groups become more sophisticated, successful companies are developing formalized structures designed to meet the needs of these key stakeholders... (ID 4261)
Companies Profiled: Abbott Laboratories, AstraZeneca Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, more ...
Price: $769.95
| |
Professional and Advocacy Relations: Launching International Efforts
|
Globalization has made access to new markets fundamental for creating new opportunities for market leadership and for partnerships with other companies seeking organizations with a solid global presence... (ID 4264)
Companies Profiled: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, more ...
Price: $516.95
| |
Measuring Medical Affairs Performance
|
Study Overview
While the medical affairs function arguably plays the most crucial role in the success or failure of a pharmaceutical company, investments made to this function are hard to measure in terms of return on investment... (ID 4632)
Companies Profiled: Abbott, Sanofi-aventis, Amgen, AstraZeneca, more ...
Price: $458.95
| |
| | |